General Catalyst Group Management, LLC

Position in GUTS — Fractyl Health, Inc.

CIK 1637946 Cambridge, MA

Position in GUTS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,236,960

-$8,508,264 QoQ

Shares Held

4,884,193

0.0% QoQ

Ownership

3.08%

of shares outstanding

% of Portfolio

1.22%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2025

4 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

General Catalyst Group Management, LLC holds $70,872,951 across 4 Biotechnology names. GUTS ranks #4 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AVBP	ArriVent BioPharma, Inc.	1,494,786	$34,484,713
2	MAZE	Maze Therapeutics, Inc.	1,035,910	$30,921,913
3	EIKN	Eikon Therapeutics, Inc.	305,233	$3,229,365
4	GUTS	Fractyl Health, Inc. This page	4,884,193	$2,236,960

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,236,960	4,884,193	0.0%	Shares	Defined	2026-05-15
2025-12-31	$10,745,224	4,884,193	0.0%	Shares	Defined	2026-02-17
2025-09-30	$7,765,866	4,884,193	0.0%	Shares	Defined	2025-11-14
2025-06-30	$7,912,392	4,884,193	—	Shares	Defined	2025-08-14
No filing history on record for this holder in this stock.